Prokidney (PROK) Capital Expenditures (2021 - 2026)

Prokidney (PROK) has 6 years of Capital Expenditures data on file, last reported at $3.8 million in Q1 2026.

• On a quarterly basis, Capital Expenditures rose 233.48% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $17.8 million, a 39.88% decrease from a year earlier, with the FY2025 full-year figure at $15.2 million, down 48.5% from the prior year.
• Capital Expenditures for Q1 2026 stood at $3.8 million, down from $5.8 million in the prior quarter.
• Over the last five years, Capital Expenditures for PROK reached as high as $27.9 million in Q3 2023 and fell as low as $306000.0 in Q4 2022.
• Historically, Capital Expenditures has averaged $5.0 million across 5 years, with a median of $1.6 million in 2023.
• Across the five-year window, Capital Expenditures jumped 8769.52% in 2023 and tumbled 91.4% in 2024, its largest moves.
• Year by year, Capital Expenditures stood at $306000.0 in 2022, then jumped by 413.73% to $1.6 million in 2023, then soared by 1522.71% to $25.5 million in 2024, then tumbled by 77.45% to $5.8 million in 2025, then sank by 34.2% to $3.8 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $3.8 million in Q1 2026, $5.8 million in Q4 2025, and $5.2 million in Q3 2025.